BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 5, 2026
See today's BioWorld
Home
» Regulatory actions for July 24, 2023
To read the full story,
subscribe
or
sign in
.
Regulatory actions for July 24, 2023
July 24, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Beigene, BMS, Daiichi Sankyo, Emergent Biosolutions, GC, Genentech, Hansoh, Ipsen, Janssen, Jazz, Menarini, Merck, Mirati, Pfizer, Scynexis, SN, Stemline.
BioWorld
Briefs
Regulatory
Regulatory actions